Wuhan BBT Medical Technology Development Co., Ltd. is a national high-tech enterprise in Wuhan, China (“China Optics Valley”), founded in 2002. We develop, manufacture, and support minimally invasive surgical systems for hospitals worldwide.
Selected milestones from the official company history.
New product lines and market programs continue to expand under the national innovation agenda; RF and ultrasonic platforms remain core to the portfolio.
Ultrasonic surgical system listed in the national Excellent Domestic Medical Equipment Product Catalog. Company recognized as a provincial “Little Giant” specialized and novel enterprise.
Multiple Class III NMPA registrations obtained for ultrasonic soft-tissue cutting and hemostasis devices (e.g. 55 kHz / 47 kHz) and disposable breast vacuum-assisted biopsy needles; several products granted invention patents.
RF ultrasonic scalpel platform adopted in 800+ tertiary hospitals in China with steady year-on-year growth.
National pilot project for the RF ultrasonic scalpel platform (MIIT / NHC). New Vaginalove pelvic health product line launched to strong clinical interest.
Quality system and regulatory footprint strengthened in line with international hospital procurement expectations.
Wholly owned subsidiary strengthens minimally invasive clinical service and training capacity.
BBT-series ultrasonic instruments received registration and entered full commercial distribution.
BBT appointed first drafter of the industry standard for gynecological RF therapy (“self-coagulation”) instruments.
Core RF product lines scaled for national hospital adoption.
Wuhan BBT Medical Technology Development Co., Ltd. founded in Wuhan “China Optics Valley” as a high-tech minimally invasive technology company.
Early technology and team formation phase preceding the formal BBT corporate structure.